Inhibition of extracellular signal-regulated kinase potentiates the apoptotic and antimetastatic effects of cyclin-dependent kinase inhibitors on metastatic DU145 and PC3 prostate cancer cells.
Rencüzoğullari, Özge
Inhibition of extracellular signal-regulated kinase potentiates the apoptotic and antimetastatic effects of cyclin-dependent kinase inhibitors on metastatic DU145 and PC3 prostate cancer cells. [electronic resource] - Journal of cellular biochemistry 04 2019 - 5558-5569 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-4644
10.1002/jcb.27840 doi
Apoptosis--drug effects
Butadienes--pharmacology
Cyclin-Dependent Kinases--antagonists & inhibitors
Humans
Male
Mitogen-Activated Protein Kinase 1--antagonists & inhibitors
Mitogen-Activated Protein Kinase 3--antagonists & inhibitors
Neoplasm Metastasis
Neoplasm Proteins--antagonists & inhibitors
Nitriles--pharmacology
PC-3 Cells
Prostatic Neoplasms--drug therapy
Inhibition of extracellular signal-regulated kinase potentiates the apoptotic and antimetastatic effects of cyclin-dependent kinase inhibitors on metastatic DU145 and PC3 prostate cancer cells. [electronic resource] - Journal of cellular biochemistry 04 2019 - 5558-5569 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-4644
10.1002/jcb.27840 doi
Apoptosis--drug effects
Butadienes--pharmacology
Cyclin-Dependent Kinases--antagonists & inhibitors
Humans
Male
Mitogen-Activated Protein Kinase 1--antagonists & inhibitors
Mitogen-Activated Protein Kinase 3--antagonists & inhibitors
Neoplasm Metastasis
Neoplasm Proteins--antagonists & inhibitors
Nitriles--pharmacology
PC-3 Cells
Prostatic Neoplasms--drug therapy